FBXW7 Inhibited M2 Macrophage Polarization in Endometrial Cancer by Reducing CCL2 Secretion Through Ubiquitination of

Jing Wu1, Xiaomei Zhang1, Wei Xu2

  • 1Obstetrics and Gynecology, Dongtai Traditional Chinese Medicine Hospital, No. 198, Yaju Road, High-Tech Zone, Dongtai, 224200, Jiangsu Province, P.R. China.

Biochemical Genetics
|January 4, 2026
PubMed

Insights

Targeting M2 macrophage polarization is key for endometrial cancer (EC) treatment. This study reveals F-box and WD repeat domain containing 7 (FBXW7) suppresses EC by degrading MYBL2, reducing CCL2 and inhibiting M2 macrophage infiltration.

Area of Science:

  • Oncology
  • Immunology
  • Molecular Biology

Background:

  • M2 macrophage polarization promotes endometrial cancer (EC) progression.
  • F-box and WD repeat domain containing 7 (FBXW7) is implicated in macrophage regulation across cancers.
  • Bioinformatics data suggest FBXW7 negatively correlates with M2 tumor-associated macrophage (TAM) infiltration in EC.

Purpose of the Study:

  • To investigate the role of FBXW7 in M2 macrophage polarization within EC.
  • To elucidate the mechanism involving the MYBL2/CCL2 axis regulated by FBXW7.
  • To evaluate FBXW7's therapeutic potential in EC progression.

Main Methods:

  • Analysis of FBXW7, MYBL2, and CCL2 expression in EC tissues.
  • Enzyme-linked immunosorbent assay (ELISA) for CCL2 quantification.
  • Immunofluorescence, flow cytometry, and western blotting for protein analysis.
  • Co-immunoprecipitation to verify protein interactions and ubiquitination.
  • In vivo tumor xenograft models in nude mice.

Main Results:

  • FBXW7 expression was decreased, while MYBL2 expression was increased in EC tissues.
  • FBXW7 overexpression reduced CCL2 secretion and M2 macrophage polarization.
  • FBXW7 promoted MYBL2 ubiquitination and degradation, consequently decreasing CCL2.
  • FBXW7 overexpression suppressed tumor growth and increased apoptosis in vivo.

Conclusions:

  • FBXW7 acts as a tumor suppressor in EC by targeting the MYBL2/CCL2 axis.
  • FBXW7 enhances MYBL2 ubiquitination and degradation, reducing CCL2 secretion from EC cells.
  • This mechanism inhibits M2 macrophage polarization, offering a potential therapeutic strategy for EC.